These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The hypertensive patient. Feferman I. Can Med Assoc J; 1980 Feb 09; 122(3):270, 273. PubMed ID: 7370820 [No Abstract] [Full Text] [Related]
9. Reserpine and breast cancer in women in germany. Kewitz H, Jesdinsky HJ, Schröter PM, Lindtner E. Eur J Clin Pharmacol; 1977 Jan 03; 11(2):79-83. PubMed ID: 837970 [Abstract] [Full Text] [Related]
12. Reserpine in hypertension: present status. Freis ED. Am Fam Physician; 1975 Jun 03; 11(6):120-2. PubMed ID: 1130256 [No Abstract] [Full Text] [Related]
13. [Is there a basis for the suggested significance of rauwolfia preparations in the development of breast cancer?]. Tikhonova NA, Lazarev NI, Samoĭlenko LA. Klin Med (Mosk); 1979 May 03; 57(5):52-6. PubMed ID: 480869 [No Abstract] [Full Text] [Related]
14. [Rauwolfia preparations and breast cancer]. Ugeskr Laeger; 1974 Nov 04; 136(45):2536. PubMed ID: 4425388 [No Abstract] [Full Text] [Related]
17. Reserpine and breast cancer in the Hypertension Detection and Follow-Up Program. Curb JD, Hardy RJ, Labarthe DR, Borhani NO, Taylor JO. Hypertension; 1982 Nov 04; 4(2):307-11. PubMed ID: 7040229 [Abstract] [Full Text] [Related]
18. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Armstrong B, Stevens N, Doll R. Lancet; 1974 Sep 21; 2(7882):672-5. PubMed ID: 4142956 [No Abstract] [Full Text] [Related]
20. Reserpine and breast cancer in a retirement community. Mack TM, Henderson BE, Gerkins VR, Arthur M, Baptista J, Pike MC. N Engl J Med; 1975 Jun 26; 292(26):1366-71. PubMed ID: 1138164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]